Recombinant TNFSF4 (Oxelumab Biosimilar) 抗体
Quick Overview for Recombinant TNFSF4 (Oxelumab Biosimilar) 抗体 (ABIN5564244)
抗原
抗体类型
适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
特异性
- Recognizes human OX40L.
-
交叉反应
- 人
-
纯度
- >95 % (SDS-PAGE)
-
内毒素水平
- <0.001EU/μg
-
免疫原
- Recombinant human OX40L.
-
亚型
- IgG1
-
-
-
-
说明
-
This antibody is a biosimilar generically called Oxelumab (CAS 1186098-83-8) and originally developed by Genentech. Oxelumab is a OX40 ligand blocker designed for the prevention of allergen-induced airway inflammation in adults with mild asthma. Potentially other application areas are transplantation and autoimmunity research or protection against inflammation-driven fibrosis.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- Lot specific
-
缓冲液
- In PBS.
-
储存液
- Without preservative
-
储存条件
- 4 °C,-20 °C
-
储存方法
-
Short Term Storage: +4°C
Long Term Storage: -20°C
Stable for at least 1 year after receipt when stored at -20°C. Stable for at least 3 months after receipt when stored at +4°C. -
有效期
- 12 months
-
-
- TNFSF4 (Oxelumab Biosimilar)
-
物质类
- Biosimilar
-
背景
- OX40L is a membrane-expressed cytokine that belongs to the TNF ligand family. It acts as costimulator through interaction with its ligand OX40 on T cells, stimulating T cell activation, proliferation and cytokine production. OX40L is expressed on antigen presenting cells including B cells, dendritic cells, mast cells and endothelium.
-
UniProt
- P23510
抗原
-